About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Omega-3-Acid Ethyl Esters
- Company
- National Cancer Institute (NCI)
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 3 recruiting
Efficacy results: Not yet reported
3 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Nov 20, 2026
Find a Clinical Trial Near Me
See recruiting studies for Omega-3-Acid Ethyl Esters and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT06195306
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
Not yet reported National Cancer Institute (NCI) 66 participants Est. completion 2028-01-01 3 sites Stand-aloneOther conditions: Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In SituView official trial listing → -
Recruiting NCT NCT07078422
Home Use Study of Targeted Mechanical Stimulation for Tremor Relief
Not yet reported Encora, Inc. 80 participants Est. completion 2026-06 1 siteOther conditions: Essential Tremor, Parkinson's DiseaseView official trial listing → -
Recruiting NCT NCT07911488
The Encora X1™ in a Real World Observational Study
Encora, Inc. 1000 participants Est. completion 2032-08 1 siteOther conditions: Essential TremorView official trial listing → -
Completed NCT NCT00004448
Alternate Day Prednisone or Daily Fish Oil Supplements in Patients With Immunoglobulin A Nephropathy
Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 96 participants Est. completion 2007-08 1 siteOther conditions: IgA GlomerulonephritisView official trial listing → -
Completed NCT NCT00069784
The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)
Not yet reported Sanofi 12537 participants Est. completion 2011-12 40 sitesOther conditions: Diabetes Mellitus, Non-Insulin-DependentView official trial listing → -
Active, not recruiting NCT NCT00135226
ASCEND: A Study of Cardiovascular Events iN Diabetes
Not yet reported University of Oxford 15480 participants Est. completion 2037-07-31 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00149409
Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure
Not yet reported, Not yet reported Medical University of Vienna Est. completion 2008-02 1 siteHeart failureView official trial listing → -
Completed NCT NCT00246636
Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate) Followed by an 8-week Extension
Not yet reported GlaxoSmithKline 167 participants Est. completion 2007-03 Stand-aloneOther conditions: HypertriglyceridemiaView official trial listing → -
Completed NCT NCT00246701
Evaluation of Efficacy and Safety of Combined Omacor (Omega-3-acid Ethyl Esters) and Simvastatin Therapy in Hypertriglyceridemic Subjects
Not yet reported GlaxoSmithKline 256 participants Est. completion 2006-06-01 Stand-aloneOther conditions: HypertriglyceridemiaView official trial listing → -
Completed NCT NCT00251134
OMEGA-Study: Effect of Omega 3-Fatty Acids on the Reduction of Sudden Cardiac Death After Myocardial Infarction
Not yet reported Stiftung Institut fuer Herzinfarktforschung 3800 participants Est. completion 2008-09 10 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT00257283
Omacor in Prevention of Cardiovascular Events in Patients Undergoing Chronic Hemodialysis
Not yet reported Pronova BioPharma 200 participants Est. completion 2005-06 1 siteOther conditions: Kidney Failure, ChronicView official trial listing → -
Completed NCT NCT00286234
Niacin, N-3 Fatty Acids and Insulin Resistance
Not yet reported University of South Dakota 68 participants Est. completion 2008-12 1 site Stand-aloneMetabolic syndrome Other conditions: HypertriglyceridemiaView official trial listing → -
Completed NCT NCT00294216
Omacor and Placebo in Carotid Plaque Stability
Not yet reported Pronova BioPharma 121 participants Est. completion 2005-07 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT00296153
Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment
Not yet reported Pronova BioPharma 51 participants Est. completion 2007-10 1 siteOther conditions: Human Immunodeficiency Virus, Ischemic Heart DiseaseView official trial listing → -
Completed NCT NCT00328536
Omacor for the Treatment of Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus
Not yet reported Ruhr University of Bochum 34 participants Est. completion 2008-11 1 siteType 2 diabetes Other conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT00346697
Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients
Not yet reported Brown, Todd, M.D., Ph.D. 48 participants Est. completion 2010-04 3 sites Stand-aloneOther conditions: HIV Infections, AIDS, Dyslipidemia, HypertriglyceridemiaView official trial listing → -
Completed NCT NCT00402363
Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation
Not yet reported GlaxoSmithKline 663 participants Est. completion 2010-01 178 sites Stand-aloneOther conditions: Fibrillation, AtrialView official trial listing → -
Completed NCT NCT00435045
Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With Hypertriglyceridemia
Not yet reported GlaxoSmithKline 245 participants Est. completion 2007-10 Stand-aloneOther conditions: HypertriglyceridemiaView official trial listing → -
Status unknown NCT NCT00437099
Efficacy of Omega-3 Fatty Acids on Borderline Personality Disorder
Not yet reported Hospital Universitari Vall d'Hebron Research Institute 102 participants Est. completion 2011-09 1 siteOther conditions: Borderline Personality Disorder.View official trial listing → -
Completed NCT NCT00446966
Fish Oil for Reduction of Atrial Fibrillation After Cardiac Surgery
Not yet reported Chirag Sandesara 260 participants Est. completion 2010-01 1 siteOther conditions: Atrial FibrillationView official trial listing → -
Completed NCT NCT00454493
The Effect of Fish Oil Supplementation on Endothelial Function, Heart Rate Variability and Intimal Media Thickness of Patients With Coronary Artery Disease
Not yet reported Olive View-UCLA Education & Research Institute 71 participants Est. completion 2008-12 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT00487591
An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed Dyslipidemia
Provident Clinical Research 40 participants Est. completion 2007-08Other conditions: Mixed DyslipidemiaView official trial listing → -
Completed NCT NCT00504309
Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides
Not yet reported Penn State University 28 participants Est. completion 2009-01 1 siteOther conditions: HypertriglyceridemiaView official trial listing → -
Withdrawn NCT NCT00507390
Omega 3 Polyunsaturated Fatty Acid Supplements (PUFAs) and Microvolt T Wave Alternans (TWA) in Patients With Ventricular Arrhythmia
Not yet reported University of Dundee Est. completion 2008-08 1 siteOther conditions: Arrhythmia, Defibrillators, ImplantableView official trial listing → -
Withdrawn NCT NCT00508248
Omega 3 Fatty Acids and Atrial Fibrillation
Not yet reported University of Dundee Est. completion 2008-11 1 siteOther conditions: Atrial FibrillationView official trial listing → -
Completed NCT NCT00515541
Lovaza's Effect on the Activation of Platelets
Not yet reported Invitrox 43 participants Est. completion 2009-06Cardiovascular disease Other conditions: BleedingView official trial listing → -
Withdrawn NCT NCT00517972
Omacor for Perimenopausal Depression
Not yet reported University of Arizona 1 siteOther conditions: DepressionView official trial listing → -
Withdrawn NCT NCT00547716
Use of Omega-3 Fatty Acids (Fish Oil) in Patients With Chronic Hepatitis C Infection
Not yet reported University of Missouri, Kansas City Est. completion 2012-08 2 sitesOther conditions: Hepatitis CView official trial listing → -
Completed NCT NCT00549692
Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A Nephropathy
Not yet reported Kuhnil Pharmaceutical Co., Ltd. 152 participants Est. completion 2012-09 5 sitesOther conditions: IgA NephropathyView official trial listing → -
Completed NCT NCT00552084
Evaluating the Effectiveness of Fish Oil Supplements at Reducing the Recurrence of Atrial Fibrillation
Not yet reported Vanderbilt University 190 participants Est. completion 2014-04 1 siteOther conditions: Atrial FibrillationView official trial listing → -
Withdrawn NCT NCT00569686
Lovaza Therapy of Peripheral Arterial Disease
Not yet reported University of Virginia Est. completion 2010-02 1 siteOther conditions: Peripheral Artery DiseaseView official trial listing → -
Completed NCT NCT00577590
Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM
Not yet reported Washington University School of Medicine 78 participants Est. completion 2012-09 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type IIView official trial listing → -
Completed NCT NCT00579436
Effects of Fish Oils on Inflammation and Insulin Resistance
Not yet reported Philip Kern 33 participants Est. completion 2015-01-15 1 siteMetabolic syndrome Other conditions: Insulin ResistanceView official trial listing → -
Terminated NCT NCT00598910
Effect of Omacor on Triglycerides in HIV Infected Subjects
Not yet reported Solvay Pharmaceuticals 51 participants Est. completion 2009-03 5 sitesOther conditions: Hyper-TriglyceridemiaView official trial listing → -
Terminated NCT NCT00672633
Trial of Lovaza in Adolescents With Mild to Moderately Elevated Triglycerides
Not yet reported Boston Children's Hospital 25 participants Est. completion 2012-03 1 site Stand-aloneOther conditions: HypertriglyceridemiaView official trial listing → -
Completed NCT NCT00678743
An Open-label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin
Not yet reported Provident Clinical Research 17 participants Est. completion 2009-09Other conditions: DyslipidemiasView official trial listing → -
Active, not recruiting NCT NCT00682318
Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers
Not yet reported Carsten Skarke, MD 40 participants Est. completion 2029-11 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT00688961
Effects of Omacor and Aspirin on Platelet Function
Not yet reported Sanford Research 10 participants Est. completion 2007-08 1 siteOther conditions: HealthyView official trial listing → -
Terminated NCT NCT00694746
Study of Fish Oil to Reduce ALT Levels in Adolescents
Not yet reported Boston University 3 participants Est. completion 2014-03 1 site Stand-aloneOther conditions: Non-alcoholic Fatty Liver Disease, Fatty LiverView official trial listing → -
Completed NCT NCT00723398
Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention
Not yet reported Milton S. Hershey Medical Center 266 participants Est. completion 2015-04 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00729430
Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging
Not yet reported Brigham and Women's Hospital 358 participants Est. completion 2014-07 1 siteCardiovascular diseaseSubstance use disorderView official trial listing → -
Terminated NCT NCT00743197
Women With Chest Pain and Normal Coronary Arteries Study
Not yet reported Northwestern University 3 participants Est. completion 2010-05 1 siteOther conditions: Chest PainView official trial listing → -
Completed NCT NCT00746811
Effects of Prescription Omega-3 on LDL-C in Primary Hypercholesterolemia
Not yet reported Provident Clinical Research 32 participants Est. completion 2010-10 1 siteOther conditions: Primary HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT00758927
The Effects of Omega-3 Fatty Acid (OMACOR) on the Low-density Lipoprotein (LDL) Sub-fraction in Type 2 Diabetic Patients
Not yet reported Inje University 70 participants Est. completion 2010-07 3 sitesType 2 diabetes Other conditions: Hypercholesterolemia, HypertriglyceridemiaView official trial listing → -
Completed NCT NCT00760513
Treatment of Non Alcoholic Fatty Liver Disease With n-3 Fatty Acids
Not yet reported University Hospital Southampton NHS Foundation Trust 103 participants Est. completion 2018-11-29 1 siteOther conditions: Non-Alcoholic Fatty Liver DiseaseView official trial listing → -
Completed NCT NCT00760760
n-3 Polyunsaturated Fatty Acids in Obesity
Not yet reported Medical University of Vienna 55 participants Est. completion 2016-03 1 siteOther conditions: Adipose Tissue Inflammation, Morbid ObesityView official trial listing → -
Completed NCT NCT00771914
The Effects of Omega-3 Fatty Acids on Aspirin Resistance
Not yet reported, Not yet reported University of Rochester 27 participants Est. completion 2009-01 1 site Stand-aloneOther conditions: Increased Drug ResistanceView official trial listing → -
Terminated NCT NCT00791089
Effects of Fish Oil on Post Ablation Arrhythmias
Not yet reported University of Michigan 12 participants Est. completion 2011-10 1 site Stand-aloneOther conditions: Atrial FibrillationView official trial listing → -
Completed NCT NCT00794079
Omega-3 Fatty Acids and Muscle Protein Synthesis
Not yet reported Washington University School of Medicine 43 participants Est. completion 2010-12 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00795717
Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial
Not yet reported Tufts University 41 participants Est. completion 2010-10 1 siteCardiovascular disease Other conditions: HIV InfectionView official trial listing → -
Completed NCT NCT00805870
The Effects of High Dose Fish Oil Supplementation on Delayed Onset Muscle Soreness and Inflammatory Markers
Not yet reported Western Michigan University 20 participants Est. completion 2010-02 1 site Stand-aloneOther conditions: Muscle Damage, Muscle InflammationView official trial listing → -
Completed NCT NCT00815685
A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia
Not yet reported H. Lee Moffitt Cancer Center and Research Institute 36 participants Est. completion 2010-08 2 sites Stand-aloneOther conditions: Cancer CachexiaView official trial listing → -
Completed NCT NCT00825994
Omega-3 for Peri- and Postmenopausal Depression
Not yet reported Massachusetts General Hospital 31 participants Est. completion 2009-06 1 siteOther conditions: DepressionView official trial listing → -
Completed NCT NCT00828178
Efficacy of Fish Oil in Lupus Patients
Not yet reported Michelle Petri M.D.,MPH 106 participants Est. completion 2011-02 2 sitesOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT00833976
Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
Not yet reported Massachusetts General Hospital 65 participants Est. completion 2013-03 1 site Stand-aloneOther conditions: High Triglycerides, Hypercholesterolemia, Schizophrenia, Schizoaffective Disorder, Bipolar DisorderView official trial listing → -
No Longer Available NCT NCT00841451
Pulmonary Vein Isolation Outcomes With Fish Oils
St. Luke's-Roosevelt Hospital Center 3 sitesOther conditions: Atrial FibrillationView official trial listing → -
Terminated NCT NCT00845845
Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)
Not yet reported University of Illinois Chicago 12 participants Est. completion 2010-10 1 siteMASH Other conditions: Hepatic SteatosisView official trial listing → -
Completed NCT NCT00891293
A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™
Not yet reported GlaxoSmithKline 93 participants Est. completion 2008-05 32 sites Stand-aloneOther conditions: HypertriglyceridemiaView official trial listing → -
Completed NCT NCT00903409
Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lovaza® and Simvastatin Therapy in Hypertriglyceridemic Subjects
Not yet reported GlaxoSmithKline 188 participants Est. completion 2008-06-27 40 sites Stand-aloneOther conditions: HypertriglyceridemiaView official trial listing → -
Completed NCT NCT00915902
Fish Oil Study for High Triglyceride Levels in Children
Not yet reported, Not yet reported Babu Balagopal 42 participants Est. completion 2012-09 3 sites Stand-aloneOther conditions: HypertriglyceridemiaView official trial listing → -
Terminated NCT NCT00930527
Omega-3-Fatty Acid on Joint Symptoms Inducted by Aromatase Inhibitors
Not yet reported Columbia University 10 participants Est. completion 2011-05 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00931879
Lovaza® and Microvascular Function in Type 2 Diabetes
Not yet reported Eastern Virginia Medical School 44 participants Est. completion 2012-07 1 siteOther conditions: Hypertriglyceridemia, Diabetic NeuropathyView official trial listing → -
Status unknown NCT NCT00934219
Triglyceride Lowering Study
Not yet reported Jewish Hospital, Cincinnati, Ohio 25 participants Est. completion 2012-12 1 siteOther conditions: HypertriglyceridemiaView official trial listing → -
Terminated NCT NCT00935766
Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries
Not yet reported Denver Health and Hospital Authority 76 participants Est. completion 2012-03 1 siteCardiovascular disease Other conditions: Metabolic Diseases, Endocrine System Diseases, Heart Disease, Vascular Diseases, Diabetes, Glucose Metabolism Disorders, HypertensionView official trial listing → -
Status unknown NCT NCT00941642
Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease
Not yet reported Huntington Medical Research Institutes 40 participants Est. completion 2012-09 1 siteOther conditions: Non-Alcoholic Fatty Liver DiseaseView official trial listing → -
Terminated NCT NCT00944229
The Effect of Omega-3 Polyunsaturated Fatty Acids in Congestive Heart Failure
Not yet reported Columbia University 58 participants Est. completion 2014-03 1 siteHeart failureView official trial listing → -
Completed NCT NCT00959842
Effects of Lovaza on Lipoprotein Composition and Function in Mild Hypertriglyceridemia
Not yet reported, Not yet reported Sanford Research 15 participants Est. completion 2010-02 1 site Stand-aloneOther conditions: HypertriglyceridemiaView official trial listing → -
Completed NCT NCT01001767
Pilot Placebo Controlled Study With Lovaza in Cardiovascular Disease
Not yet reported University Hospitals Cleveland Medical Center 35 participants Est. completion 2010-06 1 siteOther conditions: HIV Infections, Heart DiseaseView official trial listing → -
Terminated NCT NCT01002118
Feasibility Study of Omega-3 Fatty Acids in Dialysis Patients
Not yet reported University of Iowa 1 participants Est. completion 2011-02-23 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT01010399
Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects
Not yet reported Felizarta, Franco, M.D. 36 participants Est. completion 2010-11 1 site Stand-aloneOther conditions: Hypertriglyceridemia, HIV InfectionView official trial listing → -
Completed NCT NCT01034540
Effects of Prescription Omega-3 Acids on Glucose and Lipoprotein Lipids in Subjects With Hypertriglyceridemia
Not yet reported Provident Clinical Research 23 participants Est. completion 2011-02 1 siteOther conditions: HypertriglyceridemiaView official trial listing → -
Completed NCT NCT01041521
The Impact of Omega Three Fatty Acids on Vascular Function in HIV
Not yet reported Tufts University 129 participants Est. completion 2015-08 1 site Stand-aloneOther conditions: High Triglyceride Level, HIV InfectionView official trial listing → -
Status unknown NCT NCT01046604
Pilot Study of Lovaza (Omega 3 Fatty Acids) to Improve Cardiac Antioxidant/Anti-inflammatory Profile Before Cardiac Surgery
Not yet reported East Carolina University 24 participants Est. completion 2013-12 1 siteOther conditions: Mitral Valve Regurgitation, Left Atrium Dilatation and Hypertrophy, Mitochondrial Dysfunction in the Heart, Cardiomyocyte Apoptosis, Cardiac InflammationView official trial listing → -
Completed NCT NCT01047501
Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)
Not yet reported Amarin Pharma Inc. 702 participants Est. completion 2011-02 80 sitesOther conditions: HypertriglyceridemiaView official trial listing → -
Completed NCT NCT01047683
Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL
Not yet reported Amarin Pharma Inc. 229 participants Est. completion 2011-07 60 sitesOther conditions: HypertriglyceridemiaView official trial listing → -
Completed NCT NCT01048502
Fenofibrate and Omega-3 Fatty Acid Modulation of Endotoxemia
Not yet reported University of Pennsylvania 100 participants Est. completion 2011-05 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT01086163
Effects of Omega-3 Fatty Acids on Platelets in Patients With Coronary Artery Disease With Hypertriglyceridemia
HeartDrug Research LLC 30 participants Est. completion 2011-04 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT01092390
Go Fish: Omega-3 Fatty Acid Supplementation in Diabetes-Related Kidney Disease
Not yet reported Johns Hopkins University 31 participants Est. completion 2011-05 1 site Stand-aloneOther conditions: DiabetesView official trial listing → -
Completed NCT NCT01107964
Oral Omega-3 Fatty Acids in the Treatment of Dry Eye Syndrome
Not yet reported Milton S. Hershey Medical Center 27 participants Est. completion 2015-06-15 1 siteOther conditions: Dry Eye SyndromeView official trial listing → -
Terminated NCT NCT01155336
The Effects of Lovaza® in Acute Myocardial Infarction
Not yet reported, Not yet reported University of Rochester 4 participants Est. completion 2011-05 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT01157780
Parenteral Nutrition Associated Liver Disease: Early Markers and Therapy Wih Enteral Omega-3 Supplementation
Not yet reported University of Tennessee 100 participants Est. completion 2014-12 1 site Stand-aloneOther conditions: Parenteral Nutrition Associated Liver DiseaseView official trial listing → -
Active, not recruiting NCT NCT01169259
Vitamin D and Omega-3 Trial (VITAL)
Not yet reported Brigham and Women's Hospital 25871 participants Est. completion 2031-03 1 siteCardiovascular disease Other conditions: CancerView official trial listing → -
Withdrawn NCT NCT01180764
Effects of Lovaza on High Density Lipoprotein (HDL) Composition and Function in Hypertriglyceridemia
Not yet reported University of Utah Est. completion 2012-10 1 site Stand-aloneOther conditions: HypertriglyceridemiaView official trial listing → -
Withdrawn NCT NCT01191177
Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease
Not yet reported, Not yet reported Boston Children's Hospital Est. completion 2012-01 1 site Stand-aloneOther conditions: Liver Disease, Short Bowel SyndromeView official trial listing → -
Completed NCT NCT01198275
n-3 Polyunsaturated Fatty Acids (PUFAs) in the Prevention of Atrial Fibrillation
Not yet reported Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 199 participants Est. completion 2008-05 1 siteOther conditions: Atrial FibrillationView official trial listing → -
Status unknown NCT NCT01202812
A Randomized Trial of LOVAZA in Pediatric Sickle Cell Disease (SCD)
Not yet reported Thomas Jefferson University 48 participants Est. completion 2012-03 2 sites Stand-aloneOther conditions: Sickle Cell Disease, HEMOGLOBIN SS, Hemoglobin S Beta-0 Thalassemia, Inflammation, Quality of LifeView official trial listing → -
Completed NCT NCT01208961
Epanova® Compared to Lovaza® In a Pharmacokinetic, Single-dose, Evaluation
Not yet reported AstraZeneca 54 participants Est. completion 2010-11 1 siteOther conditions: Severe HypertriglyceridemiaView official trial listing → -
Status unknown NCT NCT01216982
Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders
Not yet reported United States Department of Defense 256 participants Est. completion 2011-06 1 siteOther conditions: Mood Disorders, Depression, Combat Disorders, Stress DisordersView official trial listing → -
Completed NCT NCT01223703
PUFAs and Left Ventricular Function in Heart Failure
Not yet reported Università degli Studi di Brescia 133 participants Est. completion 2009-06 1 siteHeart failure Other conditions: Dilated CardiomyopathyView official trial listing → -
Completed NCT NCT01252277
Breast Cancer Risk Biomarkers in Premenopausal Women
Not yet reported Carol Fabian, MD 36 participants Est. completion 2013-04 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01252290
Breast Cancer Risk Biomarkers in Postmenopausal Women
Not yet reported Carol Fabian, MD 35 participants Est. completion 2013-05 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01277237
The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Disease
Not yet reported University of Edinburgh 50 participants Est. completion 2012-08 1 siteOther conditions: Non Alcoholic Fatty Liver DiseaseView official trial listing → -
Completed NCT NCT01282580
Dietary Fish and Omega 3 Fatty Acids for Breast Cancer Prevention
Not yet reported Ohio State University Comprehensive Cancer Center 25 participants Est. completion 2014-08 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT01301794
Lovaza Mechanisms of Action
Not yet reported Brigham and Women's Hospital 40 participants Est. completion 2014-08 1 siteOther conditions: Moderate Hypertriglyceridemia.View official trial listing → -
Completed NCT NCT01308957
Fish Oil and Muscle Function
Not yet reported Washington University School of Medicine 77 participants Est. completion 2014-12 1 siteOther conditions: SarcopeniaView official trial listing → -
Completed NCT NCT01350973
Efficacy of TAK-085 in Participants With Hypertriglyceridemia
Not yet reported Takeda 611 participants Est. completion 2010-12 Stand-aloneOther conditions: HypertriglyceridemiaView official trial listing → -
Completed NCT NCT01350999
Long-term Efficacy and Safety Study of TAK-085 in Participants With Hypertriglyceridemia
Not yet reported Takeda 503 participants Est. completion 2011-01 Stand-aloneOther conditions: HypertriglyceridemiaView official trial listing → -
Completed NCT NCT01367145
OMEGA-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Peripheral Arterial Disease
Not yet reported Medical University of Vienna 71 participants Est. completion 2014-03 1 siteOther conditions: Peripheral Arterial DiseaseView official trial listing → -
Completed NCT NCT01422317
Effects of High-dose n-3 Fatty Acids on Clinical Outcome and Serum Lipids - Omacor Following Acute Myocardial Infarction
Not yet reported Helse Stavanger HF 300 participants Est. completion 2002-12 1 siteCardiovascular disease Other conditions: Coronary DiseaseView official trial listing → -
Completed NCT NCT01431690
Interaction of Epanova on Warfarin Pharmacokinetic and Anticoagulant Activity and Comparison of the Effects of Epanova and Lovaza on Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) After Low-fat Meals
Not yet reported AstraZeneca 52 participants Est. completion 2011-10 1 siteOther conditions: HypertriglyceridemiaView official trial listing → -
Completed NCT NCT01492361
A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin
Not yet reported Amarin Pharma Inc. 8179 participants Est. completion 2018-05 410 sitesCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT01526824
Lovaza's Effect on Clopidogrel in a Neuro Population
Not yet reported Millard Fillmore Gates Hospital 60 participants Est. completion 2013-09 1 site Stand-aloneCardiovascular disease Other conditions: Transient Ischemic AttackView official trial listing → -
Status unknown NCT NCT01577056
Postprandial Lipid Metabolism in Familial Hypercholesterolaemia:Effects of Fish Oils
Not yet reported The University of Western Australia 30 participants Est. completion 2014-03 1 siteOther conditions: Hypertriglyceridaemia, Familial HypercholesterolaemiaView official trial listing → -
Completed NCT NCT01594983
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Not yet reported Novartis Pharmaceuticals 58 participants Est. completion 2013-07 32 sitesOther conditions: Non Familial Chylocmicronemia Syndrome (Non-FCS)View official trial listing → -
Completed NCT NCT01596842
Effect of Omega-3 Fatty Acid on Vitamin D Activation
Not yet reported Dong-A University 17 participants Est. completion 2012-12 1 siteOther conditions: Hemodialysis Patients, Vitamin D Insufficiency, Vitamin D DeficiencyView official trial listing → -
Completed NCT NCT01624727
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids
Not yet reported Beth Israel Deaconess Medical Center 338 participants Est. completion 2015-01-15 2 sitesMetabolic syndrome Other conditions: Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT01630213
Impact of Vitamin D Supplementation on Cardiac Structure and Function
Not yet reported Massachusetts General Hospital 1025 participants Est. completion 2021-06-30 1 siteCardiovascular diseaseView official trial listing → -
Active, not recruiting NCT NCT01632761
Effects of Vitamin D and Marine Omega-3 Fatty Acids on Anemia
Not yet reported Brigham and Women's Hospital 2000 participants Est. completion 2025-12-28 1 siteOther conditions: AnemiaView official trial listing → -
Completed NCT NCT01632878
Omacor Plus Standard Therapies In Post Myocardial Infarction (MI) Subjects Evaluation: The OPTIMISE Observational Study
Mylan Inc. 1531 participants Est. completion 2014-12 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT01633177
Study of Vitamin D and Omega-3 Supplementation for Preventing Diabetes
Not yet reported Brigham and Women's Hospital 22220 participants Est. completion 2024-05-30 1 siteType 2 diabetesView official trial listing → -
Active, not recruiting NCT NCT01653678
Vitamin D and Omega-3 Hypertension Trial (VITAL Hypertension)
Not yet reported Brigham and Women's Hospital 25875 participants Est. completion 2026-06 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01661764
Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention
Not yet reported Vanderbilt University 141 participants Est. completion 2018-01-23 1 siteOther conditions: Colorectal Adenomatous PolypsView official trial listing → -
Completed NCT NCT01669915
A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive Decline
Not yet reported Brigham and Women's Hospital 3424 participants Est. completion 2021-12-31 1 siteOther conditions: Cognitive DeclineView official trial listing → -
Completed NCT NCT01684722
Vitamin D and Omega-3 Trial to Prevent and Treat Diabetic Kidney Disease
Not yet reported University of Washington 1312 participants Est. completion 2019-11-08 1 siteOther conditions: DiabetesView official trial listing → -
Completed NCT NCT01686568
Omega-3 Fatty Acids and Insulin Sensitivity
Not yet reported Mayo Clinic 31 participants Est. completion 2015-06-08 1 siteOther conditions: Insulin ResistanceView official trial listing → -
Completed NCT NCT01696435
VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL
Not yet reported Brigham and Women's Hospital 18353 participants Est. completion 2025-03-31 1 siteOther conditions: Depression, Depressive Symptoms, MoodView official trial listing → -
Completed NCT NCT01704859
VITamin D and OmegA-3 TriaL (VITAL): Fractures, Vitamin D and Genetic Markers
Not yet reported Brigham and Women's Hospital 25871 participants Est. completion 2022-11-23 1 siteOther conditions: FracturesView official trial listing → -
Completed NCT NCT01712867
The Effect of Phytosterol Esters of Omega-3 (Vayarol) Versus Omega-3 Acids Ethyl Esters in Reducing Triglyceride Levels
Not yet reported Enzymotec 201 participants Est. completion 2014-12 1 siteOther conditions: Patients With HypertriglyceridemiaView official trial listing → -
Completed NCT NCT01725646
An Efficacy and Safety Study of Omacor® in Taiwanese Hypertriglyceridemic Patients
Not yet reported Excelsior 253 participants Est. completion 2013-08 4 sitesOther conditions: HypertriglyceridemiaView official trial listing → -
Active, not recruiting NCT NCT01728571
LungVITamin D and OmegA-3 Trial (lungVITAL)
Not yet reported Brigham and Women's Hospital 25871 participants Est. completion 2027-11 1 siteOther conditions: COPD, Asthma, Pulmonary Function, PneumoniaView official trial listing → -
Completed NCT NCT01744067
The Effects of Omega-3 Fatty Acids in Renal Transplantation
Not yet reported Oslo University Hospital 132 participants Est. completion 2015-12 2 sitesOther conditions: Disorder Related to Renal TransplantationView official trial listing → -
Completed NCT NCT01747447
VITamin D and OmegA-3 TriaL: Effects on Bone Structure and Architecture (VITAL)
Not yet reported Brigham and Women's Hospital 771 participants Est. completion 2023-08-02 1 siteOther conditions: Bone Density, Body Composition, Bone HealthView official trial listing → -
Active, not recruiting NCT NCT01758081
Effects of Vitamin D and Omega-3 Fatty Acids on Infectious Diseases and hCAP18 (VITAL Infection)
Not yet reported Brigham and Women's Hospital 25874 participants Est. completion 2026-12 1 siteOther conditions: Infections, Human Cathelicidin Antimicrobial Peptide (hCAP-18)View official trial listing → -
Terminated NCT NCT01778647
Omega-3 Fatty Acids as an Adjunctive Therapy for Stimulants in Children With ADHD
Not yet reported Antonios Likourezos 15 participants Est. completion 2010-07 1 site Stand-aloneOther conditions: Attention Deficit Hyperactivity DisorderView official trial listing → -
Status unknown NCT NCT01782352
Age-related Macular Degeneration (AMD) in the Vitamin D and Omega-3 Trial (VITAL)
Not yet reported Brigham and Women's Hospital 25871 participants Est. completion 2024-09 1 siteOther conditions: Age-related Macular DegenerationView official trial listing → -
Withdrawn NCT NCT01784042
Dietary Energy Restriction and Omega-3 Fatty Acids on Mammary Tissue
Not yet reported Milton S. Hershey Medical Center Est. completion 2018-03 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT01785004
Vitamin D and Omega-3 Adiposity Trial (VITAL Adiposity)
Not yet reported Brigham and Women's Hospital 600 participants Est. completion 2022-07 1 siteOther conditions: AdiposityView official trial listing → -
Completed NCT NCT01813006
Effect of Omega-3 Fatty Acid on Endothelial Function
Not yet reported Nordlandssykehuset HF 34 participants Est. completion 2017-12 1 siteOther conditions: Familial HypercholesterolemiaView official trial listing → -
Completed NCT NCT01813110
Effects of a Prescription Omega-3 Fatty Acid Concentrate on Induced Inflammation
Not yet reported Penn State University 21 participants Est. completion 2015-04 1 siteOther conditions: Inflammatory ResponsesView official trial listing → -
Completed NCT NCT01821833
Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel
Not yet reported New Mexico Cancer Research Alliance 60 participants Est. completion 2022-08-03 2 sitesOther conditions: Breast Cancer, Ovarian Neoplasm, PainView official trial listing → -
Completed NCT NCT01823991
COGNUTRIN in Breast Cancer Survivors
Not yet reported H. Lee Moffitt Cancer Center and Research Institute 36 participants Est. completion 2018-05-02 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT01880463
Dry Eye Disease in the Vitamin D and Omega-3 Trial (VITAL)
Not yet reported Brigham and Women's Hospital 25875 participants Est. completion 2021-12Other conditions: Dry Eye DiseaseView official trial listing → -
Completed NCT NCT01888211
Effect of Omega 3 Fatty Acids on Vascular Function
Not yet reported University of Edinburgh 20 participants Est. completion 2009-06 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT01894581
Effects of Dietary Omega-3 Fatty Acids on Reproductive Hormones in Obese Women
Not yet reported University of Colorado, Denver 39 participants Est. completion 2014-12 1 site Stand-aloneOther conditions: Obesity, FertilityView official trial listing → -
Completed NCT NCT01929070
A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007
Not yet reported Hanmi Pharmaceutical Company Limited 12 participants Est. completion 2013-03 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT02010359
Fish Oils and Adipose Inflammation Reduction
Not yet reported University of Pennsylvania 29 participants Est. completion 2017-07-01 1 site Stand-aloneOther conditions: ObesityView official trial listing → -
Status unknown NCT NCT02035215
Phase 3 Study to Evaluate the Efficacy and Safety of Omega-3-acids Ethylesters 90 in Type Ⅱb Hyperlipidemia
Not yet reported Kuhnil Pharmaceutical Co., Ltd. 80 participants Est. completion 2014-12 4 sitesOther conditions: Hyperlipidemia, Familial CombinedView official trial listing → -
Completed NCT NCT02113163
PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPA
Not yet reported Thetis Pharmaceuticals LLC 32 participants Est. completion 2014-07 1 siteOther conditions: Diabetes Mellitus, Non-Insulin-Dependent, HypertriglyceridemiaView official trial listing → -
Completed NCT NCT02153073
Evaluation of the Safety and Efficacy of Long-term Use of Omega-3 Fatty Acid Ethyl Esters
Takeda 3084 participants Est. completion 2017-05-31 2 sitesOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT02155816
Omega 7 + 3 Combination and Systemic Inflammation
Not yet reported Appalachian State University 68 participants Est. completion 2014-08 1 siteOther conditions: InflammationView official trial listing → -
Active, not recruiting NCT NCT02178410
VITAL Rhythm Study
Not yet reported Brigham and Women's Hospital 25119 participants Est. completion 2027-10 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT02189252
An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
Not yet reported AstraZeneca 30 participants Est. completion 2015-07 4 sitesOther conditions: Severe HypertriglyceridemiaView official trial listing → -
Completed NCT NCT02285166
Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3
Takeda 15330 participants Est. completion 2020-07-14 2 sitesOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT02305355
Efficacy and Safety of Prescription Omega-3 Fatty Acid Added to Stable Statin Therapy in Patients With Type 2 Diabetes and Hypertriglyceridemia
Not yet reported Kuhnil Pharmaceutical Co., Ltd. 68 participants Est. completion 2011-02 1 siteType 2 diabetes Other conditions: HypertriglycemiaView official trial listing → -
Completed NCT NCT02370537
A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI
Not yet reported AstraZeneca 490 participants Est. completion 2015-11 22 sites Stand-aloneType 2 diabetes Other conditions: Exocrine Pancreatic InsufficiencyView official trial listing → -
Status unknown NCT NCT02625870
Omega-3-Acid Ethyl Esters 90 Soft Capsules for Lowering Very High Triglycerides
Not yet reported Jiangsu HengRui Medicine Co., Ltd. 240 participants Stand-aloneOther conditions: HypertriglyceridemiaView official trial listing → -
Completed NCT NCT02757872
Effects of Vitamin D and Fish Oil on the Kidney in Hypertensives
Not yet reported Albert Einstein College of Medicine 2232 participants Est. completion 2022-03-31 1 siteOther conditions: Hypertension, Kidney DiseasesView official trial listing → -
Completed NCT NCT02824432
Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated Dilation
Not yet reported Takeda 37 participants Est. completion 2017-08-19 4 sites Stand-aloneOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT02839902
Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood
Not yet reported Takeda 53 participants Est. completion 2017-08-30 7 sites Stand-aloneOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT02865044
Study to Evaluate the Acute Bioavailability of EPA and DHA From a DietarySupplement in Healthy Men and Women
Not yet reported Calanus 18 participants Est. completion 2015-04 1 siteOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT02899741
Efficacy of Omega-3 as Adjunctive Therapy for Medically Intractable Epilepsy: A Prospective Open-label Pilot Study
Not yet reported Seoul National University Hospital 30 participants Est. completion 2018-11 1 siteOther conditions: EpilepsyView official trial listing → -
Withdrawn NCT NCT02990091
Derivatives of Omega-3 HUFA as Biomarkers of Traumatic Brain Injury
Not yet reported University of Pennsylvania Est. completion 2023-12 1 site Stand-aloneOther conditions: TBIView official trial listing → -
Completed NCT NCT02996240
Breast, Omega 3 Free Fatty Acid, Ph 0
Not yet reported The University of Texas Health Science Center at San Antonio 21 participants Est. completion 2021-02-22 1 siteOther conditions: BreastcancerView official trial listing → -
Completed NCT NCT03018041
The Long-term Effect of Marine Omega-3 Fatty Acid Supplementation in Renal Transplantation
Not yet reported Joe Chan 174 participants Est. completion 2025-03-22 6 sitesOther conditions: Kidney TransplantationView official trial listing → -
Withdrawn NCT NCT03167164
QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy
Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28 Stand-aloneOther conditions: Merkel Cell CarcinomaView official trial listing → -
Withdrawn NCT NCT03167177
QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy
Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28 Stand-aloneOther conditions: MelanomaView official trial listing → -
Withdrawn NCT NCT03169738
QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors
Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28 Stand-aloneOther conditions: Non-small Cell Lung CancerView official trial listing → -
Withdrawn NCT NCT03169764
QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy
Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28 Stand-aloneOther conditions: Head and Neck Squamous Cell CarcinomaView official trial listing → -
Withdrawn NCT NCT03169777
QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC
Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28 Stand-aloneOther conditions: Colorectal CancerView official trial listing → -
Withdrawn NCT NCT03169790
QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHL
Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-23 Stand-aloneOther conditions: Non Hodgkin LymphomaView official trial listing → -
Withdrawn NCT NCT03175666
QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy
Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28 Stand-aloneOther conditions: Triple Negative Breast CancerView official trial listing → -
Withdrawn NCT NCT03197571
QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy
Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28 Stand-aloneOther conditions: Urothelial CarcinomaView official trial listing → -
Withdrawn NCT NCT03197584
QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy
Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28 Stand-aloneOther conditions: Ovarian CancerView official trial listing → -
Terminated NCT NCT03329248
QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
Not yet reported, Not yet reported ImmunityBio, Inc. 6 participants Est. completion 2019-11-01 1 site Stand-aloneOther conditions: Pancreatic CancerView official trial listing → -
Terminated NCT NCT03387098
QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
Not yet reported, Not yet reported ImmunityBio, Inc. 4 participants Est. completion 2019-01-15 1 site Stand-aloneOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT03415152
A Prospective Observational Program Using Digital Technology Tools to Enhance Patient Adherence to Omacor Therapy
Abbott 3000 participants Est. completion 2019-07-01 93 sitesCardiovascular disease Other conditions: HypertriglyceridemiaView official trial listing → -
Status unknown NCT NCT03438955
Phase I Drug-drug Interaction of Omega-3 and Atorvastatin
Not yet reported DongKoo Bio & Pharma 48 participants Est. completion 2018-08-31 1 siteOther conditions: Hyperlipidemia, HypertriglyceridemiaView official trial listing → -
Completed NCT NCT03443076
Bioavailability of EPA + DHA in a SMEDS Formulation
Not yet reported Midwest Center for Metabolic and Cardiovascular Research 24 participants Est. completion 2018-04-15 2 sitesOther conditions: BioavailabilityView official trial listing → -
Active, not recruiting NCT NCT03598309
Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
Not yet reported H. Lee Moffitt Cancer Center and Research Institute 19 participants Est. completion 2026-05 1 siteOther conditions: Lung Diseases, Lung Cancer, Protection AgainstView official trial listing → -
Status unknown NCT NCT03831698
Omega 3 Fatty Acids in Colorectal Cancer (CRC) Prevention in Patients With Lynch Syndrome (COLYNE)
Not yet reported University of Kansas Medical Center 21 participants Est. completion 2024-08 1 siteOther conditions: Colorectal Cancer, Lynch SyndromeView official trial listing → -
Completed NCT NCT04070833
Effects of Vitamin D and Omega-3 on Cerebrovascular Disease
Not yet reported Brigham and Women's Hospital 290 participants Est. completion 2018-09-17Cardiovascular disease Other conditions: Vitamin DView official trial listing → -
Completed NCT NCT04177680
Pharmacodynamic Effects of a Free-Fatty Acid Formulation of Omega-3 Pentaenoic Acid in Adults With Hypertriglyceridemia
Not yet reported Matinas BioPharma Nanotechnologies, Inc. 100 participants Est. completion 2021-01-18 8 sitesOther conditions: HypertriglyceridemiaView official trial listing → -
Status unknown NCT NCT04242004
Effects of Docosahexanoic Acid on Neurocognitive Impairment in HIV-infected Patients
Not yet reported, Not yet reported Fudan University 88 participants Est. completion 2020-05-01 1 site Stand-aloneOther conditions: Neurocognitive ImpairmentView official trial listing → -
Completed NCT NCT04268134
Altering Lipids for Tolerance of Aromatase Inhibitor Therapy
Not yet reported University of Michigan Rogel Cancer Center 77 participants Est. completion 2024-02-27 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04308889
Pro-Resolving Mediators in Acute Inflammation in Humans
Not yet reported Brigham and Women's Hospital 19 participants Est. completion 2022-02-22 1 site Stand-aloneOther conditions: Inflammation; Skin, Resolution, BlisterView official trial listing → -
Status unknown NCT NCT04386577
Effects of Vitamin D and Omega-3 Supplementation on Telomeres in VITAL
Not yet reported Augusta University 1054 participants Est. completion 2021-04-30 1 siteOther conditions: AgingView official trial listing → -
Completed NCT NCT04521465
Safety and Efficacy of NovaTears® + Omega-3 (0.2%) Eye Drops on Signs and Symptoms of Dry Eye
Novaliq GmbH 36 participants Est. completion 2021-02-17 2 sitesOther conditions: Evaporative Dry Eye DiseaseView official trial listing → -
Active, not recruiting NCT NCT04573946
VITamin D and OmegA-3 TriaL: Interrelationship of Vitamin D and Vitamin K on Bone (VITAL)
Not yet reported Brigham and Women's Hospital 25871 participants Est. completion 2026-12-31 1 siteOther conditions: Bone Density, Bone Health, FracturesView official trial listing → -
Completed NCT NCT04756180
An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects With Hypertriglyceridemia.
Not yet reported Abbott 248 participants Est. completion 2019-04Other conditions: HypertriglyceridemiaView official trial listing → -
Status unknown NCT NCT04907864
Effect of Multi-modal Intervention Care on Cachexia in Patients With Advanced Cancer Compared to Conventional Management (MIRACLE)
Not yet reported Kil Yeon Lee 112 participants Est. completion 2022-06-30 1 siteOther conditions: Gastric Cancer, Colorectal Cancer, Pancreatic Cancer, Biliary Tract Cancer, Lung Cancer, Precachexia, CachexiaView official trial listing → -
Terminated NCT NCT05281562
Immunonutrition for Diabetic Foot Ulcers
Not yet reported, Not yet reported Prisma Health-Midlands 1 participants Est. completion 2023-03-20 1 site Stand-aloneOther conditions: Diabetes Mellitus, Diabetic Peripheral Neuropathy, Diabetic Foot UlcerView official trial listing → -
Completed NCT NCT05613803
Poly-unsaturated Fats for Improving Nasal Polyps and Asthma
Not yet reported Norfolk and Norwich University Hospitals NHS Foundation Trust 18 participants Est. completion 2026-01-31 1 siteOther conditions: AsthmaView official trial listing → -
Completed NCT NCT06343285
Upper Limb Tremor Reduction in Essential Tremor Patients
Not yet reported Encora, Inc. 71 participants Est. completion 2024-11-12 1 siteOther conditions: Essential TremorView official trial listing → -
Terminated NCT NCT06434948
The Effect of Omega 3 Supplementation on Postoperative Delirium in Elderly Patients Undergoing Major Cardiac Surgery
Not yet reported University of Missouri-Columbia 1 participants Est. completion 2026-04-29 1 siteOther conditions: Postoperative DeliriumView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Also known as: Omega-3-Acid Ethyl Esters, Lovaza
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.
